Alvotech (ALVO) Finished Goods (2022 - 2023)
Alvotech's (ALVO) quarterly Finished Goods came in at $1.5 million in Q2 2023, down 28.62% quarter-over-quarter from $2.1 million in Q4 2022.
Powered by 
Analysis
Alvotech (ALVO) Finished Goods (2022 - 2023) Analysis & Trends
Alvotech (ALVO) has reported Finished Goods for 2 consecutive years, with $1.5 million the latest figure, recorded in Q2 2023.
- For the quarter ending Q2 2023, Finished Goods changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Jun 2023 stood at $1.5 million (changed N/A YoY), and the FY2022 full-year result was $2.1 million, changed N/A from the prior year.
- Finished Goods eased to $1.5 million in Q2 2023 per ALVO's latest filing, from $2.1 million in the prior quarter.
- Across five years, Finished Goods topped out at $2.1 million in Q4 2022 and bottomed at $1.5 million in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |